The effects of catecholamines on protein metabolism in pigs and sheep by Grisdale, Barbara S.
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1986
The effects of catecholamines on protein
metabolism in pigs and sheep
Barbara S. Grisdale
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Agriculture Commons, and the Animal Sciences Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Grisdale, Barbara S., "The effects of catecholamines on protein metabolism in pigs and sheep " (1986). Retrospective Theses and
Dissertations. 8077.
https://lib.dr.iastate.edu/rtd/8077
INFORMATION TO USERS 
This reproduction was made from a copy of a manuscript sent to us for publication 
and microfilming. While the most advanced technology has been used to pho­
tograph and reproduce this manuscript, the quality of the reproduction is heavily 
dependent upon the quality of the material submitted. Pages in any manuscript 
may have indistinct print, hi all cases the best available copy has been filmed. 
The following explanation of techniques is provided to help clarify notations which 
may appear on this reproduction. 
1. Manuscripts may not always be complete. When it is not possible to obtain 
missing pages, a note appears to indicate this. 
2. When copyrighted materials are removed from the manuscript, a note ap­
pears to indicate this. 
3. Oversize materials (maps, drawings, and charts) are photographed ty sec­
tioning the original, beginning at the upper left hand comer and continu­
ing from left to right in equal sections with small overlaps. Each oversize 
page is also filmed as one exposure and is available, for an additional 
charge, as a standard 35mm slide or in black and white paper format* 
4. Most photographs reproduce acceptabty on positive microfilm or micro­
fiche but lack clarity on xerographic copies made from the microfilm. For 
an additional charge, all photographs are available in black and white 
standard 35mm slide format.* 
*For more information about black and white slides or enlarged paper reproductions, 
please contact the Dissertations Customer Services Department. 
T T-\/f-T Dissertation 
LJIVH Information Service 
University Microfilms international 
A Bell & Howell Information Company 
300 N. Zeeb Road, Ann Arbor, Michigan 48106 

8627112 
Grisdale, Barbara S. 
THE EFFECTS OF CATECHOLAMINES ON PROTEIN METABOLISM IN PIGS 
AND SHEEP 
Iowa State University PH.D. 1986 
University 
Microfilms 
I ntern Sti O n si SOO N. Zeeb Road, Ann Arbor, Ml 48106 

The effects of catecholamines on protein metabolism 
A Dissertation Submitted to the 
Graduate Faculty in Partial Fulfillment of the 
Requirements for the Degree of 
DOCTOR OF PHILOSOPHY 
Department: Animal Science 
Maj or: Animal Nutrition 
in pigs and sheep 
by 
Barbara S. Grisdale 
Approved: 
!n Charge of Major Work 
*or the Major Department 
Iowa State University 
Ames, Iowa 
1986 
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
ii 
TABLE OF CONTENTS 
Page 
GENERAL INTRODUCTION 1 
EXPLANATION OF DISSERTATION FORMAT 14a 
ANIMAL CARE 14b 
SECTION I. EFFECTS OF EPINEPHRINE AND NOREPINEPHRINE 15 
ON LEUCINE METABOLISM IN PIGS 
ABSTRACT 17 
INTRODUCTION 18 
MATERIALS AND METHODS 20 
RESULTS 23 
DISCUSSION 34 
REFERENCES 41 
SECTION II. EFFECTS OF EPINEPHRINE, NOREPINEPHRINE AND 46 
CIMATEROL ON LEUCINE METABOLISM IN SHEEP 
ABSTRACT 48 
INTRODUCTION 49 
MATERIALS AND METHODS 51 
RESULTS 54 
DISCUSSION 70 
REFERENCES 76 
GENERAL DISCUSSION 82 
LITERATURE CITED 86 
ACKNOWLEDGEMENTS 90 
APPENDIX 91 
1 
GENERAL INTRODUCTION 
The study of the naturally occurring catecholamines, epinephrine 
(EPI) and norepinephrine (NOR), has played an important part in the 
present understanding of endocrinology. As reviewed by Tepperman (24) , 
EPI was the first hormone to be chemically identified and synthesized in 
1905. Furthermore, receptor theories were first conceptualized using 
agents which blocked the binding of catecholamines to receptors. 
Lastly, the ubiquitous second messenger, cyclic AMP (cAMP), was 
discovered by an EPI investigator. 
The adrenergic receptors were originally classified by Ahlquist (1) 
as alpha and beta, according to their responsiveness to EPI, NOR and 
other sympathomimetic amines. Subsequently, these receptor types were 
further classified into the subtypes a^, and based on 
pharmacological criteria (23). 
EPI has stimulating effects on all four receptor types, depending 
on the tissue. NOR elicits responses through a^, CKg and but has 
essentially no /gg effects (8, 23). The adrenergic receptor types, their 
target tissues and responses, as reviewed by Exton (8) and Weiner and 
Taylor (26), are listed in Table 1. Each type of receptor elicits 
responses in. numerous tissues. Furthermore, tissues such as smooth 
muscle and the pancreas may be affected positively by one type of 
receptor and negatively by another (Table 1). Tepperman (24) notes 
thou^, that the predominant effect usually masks the effects of the 
other receptors. 
A major response to stress involves stimulation of the sympathetic 
nervous system, mediated by the neurotransmitter NOR. Stimulation of 
2 
Table 1. Adrenergic receptors and their target tissues and responses' 
Receptor Tissue Response 
-Adrenergic Smooth muscle (vascular. Contraction 
iris, ureter, pilomotor, 
uterus, gastrointestinal 
and bladder sphincters) 
Smooth muscle 
(gastrointestinal) 
Liver 
Heart 
Salivary glands 
Sweat glands (localized) 
Kidney (proximal tubule) 
Brain 
Relaxation 
Glycogenolysis 
Increased force 
Secretion 
HgO secretion 
Gluconeogenesis, Na 
reabsorption 
Neurotransmission 
CKg - Adrenergic Adrenergic nerve endings 
Platelets 
Adipose tissue 
Endocrine pancreas 
Vascular smooth muscle 
Kidney 
Brain 
Inhibition of norepinephrine 
release 
Aggregation, granule release 
Inhibit lipolysis 
Inhibit insulin release 
Contraction 
Inhibit renin release 
Neurotransmission 
^Adapted from Exton (8) and Weiner and Taylor (26). 
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Table 1, continued. 
Receptor Tissue 
^-Adrenergic Heart 
Adipose tissue 
Response 
Increased rate, conduction 
velocity, contractility 
Lipolysis 
-Adrenergic Liver 
Skeletal muscle 
Smooth muscle (bronchi, 
uterus, vascular, 
gastrointestinal, 
skeletal muscle, 
spleen capsule) 
Endocrine pancreas 
Salivary glands 
Glycogenolysis, 
gluconeogenes is 
Glycogenolysis, lactate 
release, increased 
contractility, K uptake 
Relaxation 
Insulin secretion 
Anylase secretion 
the adrenal medulla also occurs, resulting in release of EPI and NOR 
into the general circulation (26). These actions result in simultaneous 
responses over the entire body. Weiner and Taylor (26) state that the 
result of this is that; 
"The heart rate is accelerated; the blood pressure rises; 
red blood cells are poured into the circulation from the 
spleen (in certain species) ; blood flow is shifted from 
the skin and splanchnic region to the skeletal muscles ; 
blood glucose rises; the bronchioles and pupils dilate ; 
and, on the whole, the organism is better prepared for 
• fight or flight.'" 
4 
Galbo et al. (9) and Tepperman (24) have described resting plasma 
concentrations of EPI and NOR in man to be about 0.05 ng/ml and 0.2 to 
0.4 ng/ml, respectively. In contrast, the stress of nyocardial 
infarction (24) has been reported to increase plasma concentrations of 
EPI to 0.27 ng/ml and NOR to 4.1-ng/ml. Heavy exercise in ma-n (9) 
increased the concentration of epinephrine to as high as 0.42 ng/ml and 
that of NOR to 2.22 ng/ml. Kozlowski et al. (14) reported that food 
deprivation in dogs increased the concentration of EPI from 
approximately 0.3 ng/ml after 4 h to about 0.7 ng/ml after 96 h. The 
concentration of NOR similarly rose from approximately 0.9 ng/ml to 2.8 
ng/ml during the fast. 
The second messengers involved in the response to the 
2+ 
catecholamines include both Ca and cAMP. The and adrenergic 
receptors elicit responses through mechanisms involving activation of 
adenylate cyclase, while receptors inhibit adenylate cyclase (23). 
The activation of adenylate cyclase promotes the accumulation of 
intracellular cAMP, which then leads to the activation of other enzymes 
such as cAMP-dependent protein kinase. These kinases phosphorylate and 
activate other enzymes which catalyze the final physiological response. 
The initial step in o:^-adrenergic receptor action involves the 
breakdown of phosphatidylinositol-4,5-bisphosphate in the plasma 
membrane of target cells, producing myo-inositol-1,4,5-triphosphate (IP) 
and 1,2-diacylglycerol (8). The IP acts to rapidly mobilize 
2+ intracellular stores of Ca , which then bind to calmodulin. The 
2+ 
physiological response is produced when the Ca -calmodulin complex 
activates calmodulin-dependent protein kinases (8). The diacylglycerol 
5 
2+ is thought to activate a Ca -phospholipid-dependent protein kinase 
which also phosphorylates certain enzymes and generates subsequent 
physiological responses (8). 
As indicated in Table 1, which was adapted from recently published, 
comprehensive tables of Exton (8> and Weiner and Taylor (26) , listing 
the adrenergic receptors and their responses in effector organs, no 
mention is given of effects of adrenergic agonists on protein tiimover 
in any tissue. A 1955 review (22) of the hormonal control of amino acid 
metabolism indicates thou^, that acute effects of EPI injections on 
protein metabolism were recognized as long as 50 years ago. The 
injections of EPI in rats resulted in a decrease in plasma amino 
nitrogen concentration and an increase in urea nitrogen excretion (22). 
The breakdown of protein has been shown in vitro to be influenced 
by adrenergic compounds. Garber et al. (10) reported decreased rates of 
release of alanine and glutamine from preparations of rat epitrochlaris 
muscle, when EPI, NOR or isoproterenol (non-specific )3-agonist) were 
added to the incubation media. The addition of the a-adrenergic 
blocker, phentolamine, to the media did not prevent the inhibitory 
effect of EPI on amino acid release, whereas the addition of 
propranolol, a J3-adrenergic antagonist, resulted in a reversal of EPI's 
effect. The authors concluded from these studies that the effect of the 
catecholamines on protein degradation was mediated by adrenergic 
receptors. It has been noted though, that these results could be the 
result of either a reduction in protein degradation, as the authors 
suggested, and/or an increase in protein synthesis. An increase in 
protein synthesis would reduce the availability of substrate for the de 
6 
novo synthesis of alanine and glutamine, and thus the concentration of 
these amino acids in the media would be lower (7, 15). Li and Jefferson 
(15) also reported that perfusion of the isolated rat hemicorpus with 
isoproterenol resulted in a decrease in the rate of protein degradation, 
14 
as measured by the dilution of -C-phenylalanine specific radioactivity 
in the media by unlabelled phenylalanine released from protein. 
Evidence of an adrenergic effect on protein degradation in vivo was 
described by Miles et al. (18). In their study, post-absorptive humans 
were given a constant infusion of EPI sufficient to increase plasma EPI 
concentrations to stress levels. During this experiment, a decrease in 
the rate of appearance of leucine carbon in the plasma was indicative of 
reduced proteolysis. 
Effects of adrenergic compounds on protein synthesis have also been 
described. EPI and NOR have been demonstrated to reduce the 
14 incorporation of C-histidine into isolated rat diaphragms (27). 
However, there was no effect of isoproterenol on phenylalanine uptake 
into rat gastrocnemius muscles (15). In contrast to these in vitro 
studies showing decreases or no change in protein synthesis, chronic 
administration of the - adrenergic agonists clehbuterol and fenoterol 
to rats for 16 to 19 d (7), resulted in increases in protein synthesis 
in the gastrocnemius muscle, of 34 and 26%, respectively. 
The effect of adrenergic stimulation on amino acid oxidation has 
not been well studied. In dogs fasted for 24 h and treated for 4 h with 
-1 -1 
a constant infusion of 0.1 or 0.5 pLg*kg *min EPI (16), the urea 
production rate did not significantly change from the control period. 
Liddell et al. (16) used the urea production rate as an indicator of net 
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protein breakdown or protein oxidation. An in vitro analysis of the 
effect of EPI on oxidation of amino acids in rat hemidiaphragms was 
reported by Btise et al. (4). It was determined that EPI could only 
stimulate the rate of leucine oxidation when the diaphragms were from 
fasted animals and when glucose and pyruvate were omitted from the 
media. Alanine oxidation was also stimulated in diaphragms from fasted 
rats treated with EPI, but no effect was found on histidine oxidation. 
The authors noted that the stimulation of branched chain aminm acid 
oxidation in muscles from fasted animals may be secondary to the 
lipolytic effect of EPI in the fasted state, since branched chain amino 
acid oxidation is inhibited by fatty acids. 
The first experiments illustrating effects of chronic 
administrations of EPI on storage of protein and fat in the intact 
animal may be those of Cunningham and associates (5). These authors 
showed that daily subcutaneous injections of 0.125 mg/kg EPI in com oil 
for 6 weeks, significantly increased the percentage protein in the 
carcasses of young pigs, while reducing the fat content. Further 
investigations into the effects of adrenergic compounds on body 
composition were not reported until 1983. The renewed interest in these 
compounds may be due to the increased demand by consumers for leaner 
meat products. 
In recent years, the effects of jS-agonists on animal performance 
and carcass muscle and fat content have been well-illustrated. A 
summary of the performance and carcass composition data from 
representative experiments in studies in which ^ -agonists or EPI were 
fed or injected into animals is given in Table 2. Clenbuterol (7) and 
Table 2. Effects of feeding and injections of adrenergic agonists on 
animal performance and carcass composition 
% Change from control 
Animal Agonist Dosage 
Initial 
Weight 
Time on 
Study ADG* G/F^ LMA® 
Fat 
depth 
Steers^ GLEN® 10 ppm 350 kg 98 d -8 -1 +11* -35**^ 
Lambs® GLEN 2 ppm 41 kg 8 wk +24** +19** +41** -37**^ 
Lambs^ CIM^ 10 ppm 17 kg 6 wk -3 +6 +26* -48*^ 
Swine^ GXM 1 ppm 60 kg 49 d +4 +12* +12* -10*^ 
Swine™ EPi" .125 mg/kg° 8 kg 6 wk -17 -21 +5*P -10^ 
Broilers ^ GLEN 1 ppm 786 g 49 d +5**® +5**3 +2*^ -7*" 
Rats^ GLEN 1 mg/kg" 150 g 16 d +27** +22*** -5? 
f Average dally gain. 
Gain to feed ratio. 
jLongissimus muscle area. 
^icks et al. (21). 
®Clenbuterol. 
^12th rib. 
fsaker et al. (2). 
.Beerman et al. (3). 
.Clmaterol. 
•^Average of 2 measures over the longisslraus and 2 over the rib. 
^Jones et al. (13). 
Last rib. 
^Cunningham et al. (5). 
Epinephrine. 
Subcutaneous injection once daily. 
^Carcass protein as a percentage of carcass dry matter, 
^Percentage carcass fat. 
^Dalrymple et al. (6). 
^Females and males combined. 
Percentage carcass protein in females. 
Percentage carcass fat in females. 
Emery et al. (7). 
Subcutaneous injections given twice daily. 
Body protein content. 
^Body fat content. 
* P<0.05 Denotes significantly different from controls. 
** P<0.01 Denotes significantly different from controls. 
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cimaterol (R. H. Dalrymple, American Cyanamid, Princeton, NJ, personal 
communication) are regarded as -adrenergic agonists. The feeding of 
these compounds at low levels produces significant changes in the body 
composition of steers (21), lambs (2, 3), pigs (13), poultry (6) and 
rats (7). Significant increases -in muscle size or percentage carcass 
protein was seen in all species tested, and a decrease in fat content 
was observed in all animals except rats. The effects of these compounds 
on body composition can be influenced by sex. Dalrymple et al. (6) 
reported that the response to clenbuterol in female broilers was greater 
than that in males. 
Animal performance is not improved as consistently as body 
composition (Table 2) and may be influenced by animal maturity. In 
experiments involving lambs put on test at three different wei^ts. 
Baker et al. (2) reported inconsistent average daily gain and feed 
conversion efficiency results when clenbuterol was fed to lambs put on 
test at weights of 33 and 37 kg, in comparison to the results obtained 
with lambs put on test at 41 kg. At high levels, these compounds can 
also negatively affect average daily gain (21). 
These studies indicate that adrenergic compounds seem to influence 
muscle protein metabolism. In an attempt to better understand the 
details of the changes which may occur in protein metabolism during 
administration of adrenergic compounds, a two-pool model of protein 
turnover has been used. Several two-pool models involving the essential 
amino acid leucine and its keto-acid, a-ketoisocaproate (KIC), have been 
proposed (11, 17, 20). Practical and theoretical considerations of such 
models has been discussed by Helland et al. (12). 
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The initial step in protein turnover (Fig. 1) is the liberation of 
amino acids from the tissue protein pool. As in the case of leucine, 
the liberated amino acid can then be used to resynthesize protein or be 
catabolized (oxidized) for energy or used in the production of other 
14 
substrates. In this model, [ C}-leucine is used to label the body 
3 leucine pool and [ H]-KIC is used to label the body KIC pool. In the 
fed state, this model is complicated by leucine entering the body pool 
from absorption of the diet. The dietary contribution can be estimated 
13 if an additional label, such as [ C]-leucine, is utilized in the feed 
(20).  
Figure 1. Whole-body leucine metabolism model. [^^C]leucine anH 
[^H]KIC infused 
13 
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14a 
EXPLANATION OF DISSERTATION FORMAT 
This dissertation is presented in the alternate format, as outlined 
in the Iowa State Graduate College Thesis Manual. Use of the alternate 
format allows for the preparation of independent sections that are 
suitable for submission to scientific journals. 
Two separate papers have been prepared from the data collected from 
research performed to partly fulfill requirements for the Ph.D. degree. 
Each paper is complete in itself and has an abstract, introduction, 
materials and methods, results, discussion and reference section. The 
closeness of the subject matter of the two papers allowed a general 
discussion to be prepared. 
14b 
ANIMAL CARE 
The animals used in the following trials were treated in accordance 
with the Iowa State University animal care guidelines. 
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SECTION I. EFFECTS OF EPINEPHRINE AND NOREPINEPHRINE ON LEUCINE 
METABOLISM IN PIGS 
16 
EFFECTS OF EPINEPHRINE AND NOREPINEPHRINE 
ON LEUCINE METABOLISM IN PIGS^ 
Barbara Grisdale-Helland, Stale J. Helland and Steven Nissen 
Department of Animal Science, 
Iowa State University, 
Ames, Iowa 50011 
^This project was supported in part by National Institute of Health 
Grant 31470 and by the Iow:a Agriculture and Home Economics Experimental 
Station. 
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ABSTRACT 
Whole-body leucine and a-ketoisocaproate (KIC) metabolism was 
estimated' in young pigs during infusions of stress levels of 
epinephrine (EPI, 0.1 jig*kg ^*min ^ ) , norepinephrine (NOR, 
-1 -1 2.0 ^tg*kg *min ) or the saline-vehicle. A constant infusion of 
14 3 [1- C]leucine and [4,5- H]KIC was employed to estimate the rates of 
whole-body protein degradation, protein synthesis, KIC oxidation and 
interconversion of leucine and KIC. EPI infusion resulted in decreases 
in proteolysis and protein synthesis of 15 and 18%, respectively. NOR 
infusion resulted in decreases in proteolysis, protein synthesis and 
oxidation of 25, 25 and 24%, respectively. Leucine and KIC 
interconversion also decreased during the NOR infusion. Free fatty acid 
concentrations increased threefold and glucose concentrations increased 
twofold during the NOR infusion. Glucose was also elevated by 30% 
during the EPI infusion. Insulin concentrations did not change during 
any treatment, but glucagon and Cortisol concentrations were increased 
by NOR. These data suggest that the liberation of energy-producing 
substrates from glycogen and adipose tissue was sufficient to reduce the 
need for amino acid oxidation during the NOR infusion, but was 
insufficient to decrease oxidation during the EPI infusion. Therefore, 
in stress situations, decreases in protein turnover will conserve energy 
and thus, augment the desired increase in readily available energy. 
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INTRODUCTION 
Epinephrine (EPI) and norepinephrine (NOR) have an important 
function in mobilizing readily available energy for body tissues during 
periods of stress. This is achieved by enhancing glucose availability 
through increased glycogenolysis in liver and muscle (7, 13), and the 
augmentation of lipolysis (35) for the providing free fatty acids (FFA) 
for energy and glycerol for gluconeogenesis. The muscle protein also 
represents a potential energy store which could be liberated during 
periods of stress, although it is regarded as a less efficient energy 
source, because of the energy requirement associated with detoxification 
of the nitrogen waste (15). Furthermore, since protein synthesis, and 
perhaps protein degradation, are energy requiring processes (24), the 
energy expenditure of the animal can be influenced by changes in protein 
metabolism. 
Several in vitro experiments have indicated that perfusion of rat 
muscle with EPI or NOR results in a decrease in the rate of release of 
amino acids (6) and a decrease in the rate of amino acid incorporation 
(34) . An in vivo study with humans, in which EPI was infused for 3 h 
(20), also showed decreased appearance of leucine carbon in plasma, 
indicative of reduced proteolysis. The rate of amino acid oxidation has 
been shown to increase upon perfusion of rat diaphragm muscle with EPI 
(4), although oxidation was suppressed when pyruvate or glucose was 
added to the media. When EPI was infused into fasted dogs (19), 
however, no influence on the rate of protein oxidation was observed. 
These studies suggest that EPI and NOR influence certain aspects of 
protein metabolism. It was not clear from this information, however. 
19 
what the magnitude of these effects would be in relation to each other, 
since only one aspect of protein metabolism was usually analyzed. Thus, 
the objectives of the present experiment were to study the influence of 
constant infusions of EPI and NOR on leucine metabolism (protein 
synthesis, protein degradation, leucine and a-ketoisocaproate (KIC) 
interconversion and leucine oxidation) at the whole-animal level, and 
also to observe changes occurring in the concentrations of several 
metabolites and hormones as a result of these infusions, in pigs. 
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MATERIALS AND METHODS 
L-[1-^^C] leucine (57 mCi/nnnol) was purchased from Amersham and 
3 
L-[4,5- H]leucine (58 Ci/mmol) was purchased from ICN Biomedicals. 
3 3 [ H]KIC was enzymatically prepared from [4,5- H]leucine (27). EPI and 
NOR (arterenol hydochloride) were obtained from Sigma Chemical. The 
drugs were dissolved in a 0.9% sodium chloride solution containing 0.2% 
serum albumin. 
Six female pigs (23 kg) were used in a cross-over design. Each 
animal was surgically implanted with an infusion catheter in the left 
ventricle via the carotid artery and a sampling catheter in the right 
ventricle via the internal jugular vein, 4 to 6 days before 
experimentation. 
The pigs were fasted for 24 h before the start of each experiment. 
Two d of normal feeding separated each experiment day. A primed-dose 
constant infusion of [^H]KIC and [^^C]leucine (1.5 and 0.6 fiCi*min~^, 
respectively) was started at approximately 8 am. The priming dose was 
ten times the constant infusion dose for one min. The start of the 
treatment infusions was delayed for 2 h to allow for equilibration of 
the isotopes. Before the start of the treatments, four blood samples 
were taken in the latter 15 min of the basal steady state period. At 
zero time, a 2 h constant infusion of EPI (0.1 ;ig*kg ^*min"^) or NOR 
(2.0 pt.g*kg ^*min ^) was started. Two of the pigs were also studied 
during infusion of the saline-albumin vehicle. After the start of the 
treatment, blood was sampled at 10, 20, 30, 45, 60, 75, 90, 105 and 120 
minutes. The blood was collected into tubes containing EDTA and cooled 
immediately on ice. One ml of whole blood was added to tubes containing 
21 
3 ml 1.5 N perchloric acid and frozen at -80 C for later analysis. The 
remaining blood was centrifuged and the plasma was collected and stored 
at -80 C until analyzed for hormones and metabolites. Trasylol (500 
U/ml of plasma) was added to the samples which were to be analyzed for 
glucagon. 
Whole-blood leucine and KIC concentrations were determined by high-
performance liquid chromatography (HPLC, 22). The HPLC effluent 
corresponding to the leucine or KIC peaks was collected and the ^^C and 
3 
H radioactivity determined by dual isotope liquid scintillation 
counting. 
Plasma glucose concentrations were determined using the glucose 
oxidase method (Worthington Diagnostics). Free fatty acid 
concentrations were analyzed enzymatically (29). Radioimmunoassays were 
used to measure insulin (33), glucagon (8) and Cortisol (Gammacoat 
125 [ I] Cortisol Radioimmunoassay Kit, Travenol-Genetech Diagnostics) . 
Rates of entry (proteolysis) and exit (protein synthesis) of 
leucine, exit of KIC (oxidation), and interconversion of leucine and KIC 
were calculated as described by Helland (9) for a reversible two-pool 
model. The specific radioactivities of ^ ^C-leucine and ^^C-KIC were 
found to be nonsignificantly different from each other and therefore, 
the average specific radioactivity of these two components was used in 
the flux calculations (9, 10). 
It was subsequently determined that the plasma concentrations and 
specific radioactivities of leucine and KIC were constant between 75 and 
120 min after the start of the hormone infusions, and thus a new steady 
state had been established. The Student's t-test (30) was used to 
22 
determine whether the change from the basal (mean of -15 to 0 min) to 
the final period (mean of 75 to 120 min), for each variable, was 
statistically different from zero. Because there were only 2 saline-
infused animals, comparisons between treatments were not made. Data are 
presented as means + SE. 
23 
RESULTS 
The whole-blood concentrations of leucine and KIC In the basal and 
final periods are presented In Table 1. Leucine concentrations 
decreased significantly during the EPI infusion, while KIC 
concentrations decreased significantly during the NOR infusion. 
Rates of proteolysis, protein synthesis. Interconversion of leucine 
and KIC, and KIC oxidation, in the basal and final periods, for each 
treatment, are also presented in Table 1. 
Both EPI and NOR infusions resulted in significant decreases in 
proteolysis (15 and 25%, respectively). Similarly, the rate of protein 
synthesis decreased by 18% during the EPI Infusion and 25% during the 
NOR infusion. Leucine and KIC interconversion was not affected by EPI 
infusion, but during the NOR infusion deamlnation of leucine to KIC 
decreased by 29% and reaminatlon was reduced by 30%. Only the Infusion 
of NOR resulted in a significant change in KIC oxidation (0.82 to 0.62 
fimol*kg"^*min"^). 
No significant effects of the infusion of EPI were seen in the 
plasma concentrations of FFA in these pigs (Fig. 1). The infusion of 
NOR, however, resulted in a trebling of FFA concentrations by 20 min. 
This level was maintained throu^out the infusion, resulting in a 
significant increase from the basal to the final period (592 + 109 to 
1870 + 85 nmol/ml). 
The infusion of EPI resulted in a significant change in glucose 
concentrations from the basal to the final period (91 + 1 to 119 + 7 
mg/dl). This change was more gradual than that observed with the 
Table 1. Leucine and KIC concentrations and leucine metabolism before, 
and during, infusion of saline, epinephrine or norepinephrine 
Time Saline Epinephrine Norep inephr ine 
(3-2) (N-6) (N-6) 
Concentrations^ 
Leucine 125 
129 
137 + 13 
108 + 8* 
152 + 12 
136 + 5 
KIC B 
F 
29.4 
26.6 
21.7 + 1.6 
27.4 + 1.4 
28.6 + 1.9 
20.8 + 1.1* 
Fluxes'^ 
Proteolysis B 
F 
4.32 
3.93 
4.90 + 0.28 
4.17 + 0.23** 
5.32 + 0.31 
3.99 + 0.23** 
Synthesis B 
F 
3.54 
3.17 
4.19 + 0.25 
3.44 + 0.17* 
4.50 + 0.31 
3.37 + 0.23** 
Leu > KIC B 
F 
2.49 
2-68 
3.46 + 0.30 
3.50 + 0.33 
3.85 + 0.52 
2.72 + 0.33** 
KIC > Leu B 
F 
1.72 
1.92 
2.75 + 0.33 
2.77 + 0.31 
3.02 + 0.50 
2.10 + 0.31** 
Oxidation B 
F 
0.78 
0.76 
0.71 + 0.10 
0.73 + 0.09 
0.82 + 0.07 
0.62 + 0.07* 
^nits: /iM + SE. 
^Basal time period (-15 to 0 min). 
^Final time period (75 to 120 min). 
^nits: pimol leucine or KIC*kg'^*min'^ + SE. 
* Change from basal to final period significantly different from 
zero (P<0.05). 
** Change from basal to final period significantly different from 
zero (P<0.01). 
Figure 1. Plasma free fatty acid concentrations in young pigs before, 
and during infusion of saline, epinephrine or norepinephrine. 
Significance between basal and final periods is denoted by 
**P<0.01, within a treatment. 
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infusion of NOR though, where glucose concentrations had doubled by 20 
min after the start of the infusion (Fig. 2). Glucose concentrations 
reached a plateau at about 45 min after the start of the NOR infusion. 
This level was maintained through to the end of the infusion, resulting 
in a significant change from the -basal to the final period (89 + 5 to 
198 + 25 mg/dl). 
There were no significant changes in the plasma concentrations of 
insulin during any of the infusions (overall mean 0.15 + 0.03 ng/ml). 
After an initial rise in glucagon concentrations during the EPI 
infusion (Fig. 3), the level returned to baseline and no significant 
change was observed from the basal to the final period. Plasma glucagon 
concentrations increased rapidly upon the start of the NOR infusion, 
reaching a peak by 10 min. From the basal to the final period, NOR 
infusion resulted in a significant increase in the plasma concentrations 
of glucagon from 142 + 11 to 367 + 79 pg/ml. 
No significant effects on plasma Cortisol concentrations were 
observed during the EPI infusion (Fig. 4). Plasma Cortisol 
concentrations Increased slowly during the infusion of NOR, peaking at 
90 min. Overall, NOR resulted in a significant increase in Cortisol 
concentrations from a basal level of 9.5 + 1 to a final level of 
21.1 + 2.0 fxg/dl (P<.05). 
Figure 2. Plasma glucose concentrations in young pigs before, and 
during infusion of saline, epinephrine or norepinephrine. 
Significance between basal and final periods is denoted by 
**P<0.01, within a treatment. 
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Figure 3. Plasma glucagon concentrations in young pigs before, and 
during infusion of saline, epinephrine or norepinephrine. 
Significance between basal and final periods is denoted by 
*P<0.05, within a treatment. 
600 
500 
N400 
0» 
a 
w 
2 300 
O 
o 
< 
o 200 
-I 
o 
100 
BASAL 
• -i- Norepinephr Ine 
X* - -K Epinephr ine 
Sa 1i ne 
FINAL 
+•••••+- .  
.4- • 
4-
-20 20 40 60 
T IME (M IN)  
80 100 120 
Figure 4. Plasma Cortisol concentrations in young pigs before, and 
during infusion of saline, epinephrine or norepinephrine. 
Significance between basal and final periods is denoted by 
*P<0.05, within a treatment. 
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DISCUSSION 
The infusion rates of EPI and NOR used in the present studies were 
designed to mimic levels which would be expected in stress situations. 
Blum et al. (3) noted that an infusion of approximately 72 ng*kg~^*min"^ 
EPI in fed cattle resulted in a plasma EPI concentration of about 1500 
-1 -1 pg/ml. An infusion of 50 ng*kg *min EPI in humans (25) resulted in 
an increase in the plasma EPI concentration from 34 to 776 pg/ml and no 
change in plasma NOR concentration. Stresses such as exercise in man 
(5) and food deprivation in dogs (17) have been reported to result in 
EPI concentrations of 400 to 700 pg/ml. 
Infusions of 40 (28) and 80 ng*kg"^min"^ (14) NOR in humans have 
been reported to raise plasma NOR concentrations to 1500 to 1800 pg/ml. 
Because these NOR levels were not as high as those which have been 
reported to occur during stresses (5, 17, 32) such as exercise (2200 
pg/ml), food deprivation (2800 pg/ml) or myocardial infarction (4100 
pg/ml) , an infusion rate of 2000 ng*kg ^*min ^  was chosen. The levels 
of EPI and NOR infused are markedly different and thus, no direct 
comparisons between the effects of the two hormones can be made. 
The infusion of 0.1 fig*kg ^*min ^ EPI into the pigs produced 
significant decreases in whole-body protein degradation. This result 
agrees with in vitro work, in which rat epitrochlaris muscle (6) was 
perfused with EPI, and decreased release of amino acids was observed. 
This finding is also in agreement with a human study (20), in which a 3 
-1 -1 h infusion of 50 ng*kg *min of EPI resulted in a decrease in the rate 
of appearance of leucine carbon in the plasma. 
The infusion of 2.0 fig*kg ^*min ^ NOR into the fasted pigs also 
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resulted in a decreased rate of proteolysis in the whole body. This 
observation is consistent with an in vitro study, in which perfusion of 
rat epitrbchlaris muscle with NOR decreased the release of glutamine and 
alanine into the media (6) . 
The rate of protein synthesis was significantly decreased during 
the infusion of EFI in the fasted animals. This result is supported by 
research in which subcutaneous injections of EPI in rats, 2 h before 
killing, resulted in a decrease in the incorporation of phenylalanine 
into muscle protein (34). When EPI was included in the incubation media 
of rat diaphragms (34), the incorporation of labelled amino acids was 
also decreased. Other in vitro research, however, has shown no effects 
of EPI on the uptake of amino acids into rat diaphragms (23) . The 
decrease in protein synthesis in the pigs infused with EPI was of the 
same magnitude as that in protein degradation. Thus, it is not clear 
from this information whether EPI has a direct effect on synthesis or if 
the decrease in synthesis was a secondary result of the reduced amino 
acid availability caused by decreased proteolysis, and reflected in the 
decreased leucine concentration. 
Similar to EPI, the infusion of NOR also resulted in decreased 
whole-body protein synthesis, which is consistent with in vitro work 
demonstrating NOR decreases amino acid incorporation into muscle (34), 
The rates of interconversion of leucine and KIC significantly 
decreased during the infusion of NOR. No effects on leucine and KIC 
interconversion thou^, were found during the infusion of EPI. This is 
in contrast to a study involving humans (20), in which EPI infusion 
increased the rate of transfer of leucine nitrogen to alanine, while 
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decreasing the rate of irreversible loss of leucine carbon, indicative 
of an increase in leucine-KIC transamination. 
Two h of NOR infusion into the fasted pigs resulted in decreased 
KIC oxidation. This may be the result of decreased availability of 
substrate, which is reflected in the decreased KIC concentrations during 
the NOR infusion. 
In the present study, the rate of leucine oxidation was not 
significantly affected when EPI was infused. Previous studies in dogs 
(19) infused with 0.1 or 0.5 fig*kg ^*min ^ of EPI also forced no change 
in amino acid catabolism, as estimated by measuring urea production. 
The incubation of diaphragm muscle from both fed and fasted rats with 
EPI (4), however, enhanced branched-chain amino acid oxidation when 
pyruvate and glucose were omitted from the media. 
The observation that no significant alterations occurred in the 
concentrations of FFA during the infusion with EPI was surprising, 
because continuous infusions of EPI over periods of 30 min to 6 h have 
previously been shown to significantly Increase FFA concentrations in 
cattle (3), humans (20), sheep (1, 12), pigs (11) and dogs (19). 
Differences in dosages and conditions of the animals in each experiment 
may account for this apparent discrepancy. 
The increase in FFA concentrations resulting from the infusion of 
NOR in the pigs agrees with previous research in cattle (3), sheep (1) 
and humans (14) . 
Glucose concentrations have been shown to increase significantly 
during EPI infusions in humans (20), pigs (11), sheep (1, 12) and cattle 
(3). Those results agree with that found in the present study. It is 
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not possible to tell from the methods used in the present experiment 
whether the increased glucose is the result of increased production of 
glucose and/or decreased removal of glucose from the plasma. A glucose 
turnover study in fasted humans (26) indicated thou^, that a 3 h 
infusion of EPI, at half the rate used in the present experiment, 
resulted in an initial increase in the rate of glucose appearance in the 
plasma from 15 to 75 min. This was followed by a return to the basal 
rate. The rate of glucose clearance, however, was significantly lower 
tiian the basal rate during the period from 30 to 180 min after the start 
of the EPI infusion (26). These flucuations in turnover resulted in 
increased plasma glucose levels from 60 to 180 min. Results observed 
when dogs were infused with EPI (13) indicated, however, that despite 
increased hepatic glucose production and peripheral glycogenolysis, the 
rate of glucose clearance was not significantly altered. 
Infusions of NOR have been shown to result in increases in glucose 
concentrations in humans (14), while having no effect in sheep (1) . The 
present results indicate that pigs also respond to NOR infusion with 
increases in glucose concentrations. 
The combined results for glucose and FFA during the EPI and NOR 
infusions, support the general concept that these hormones increase the 
supply of readily available energy in stress situations. 
In agreement with the present experiment, higher levels of EPI than 
that used in the present study, also produced no effect on insulin 
concentration in pigs fasted for 18 h (11), Experiments involving the 
infusion of EPI Into humans (20, 24, 25), at lower levels than that used 
in the present experiment, however, have shown EPI increases insulin 
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concentrations. Thus, the effect of EPI on insulin may be related to 
the dosage infused, condition of the subjects and/or species 
differences. 
-1 -1 
The infusion of 2 Mg*kg *min NOR produced no change in insulin 
concentrations in the pigs. The-infusion of 0.04 ptg*kg"^*mln"^ NOR into 
humans (28) , thou^, lias been shown to cause a decrease in insulin 
concentrations during the first 30 min of infusion. This was followed, 
however, by a return to basal levels during the next 30 min of infusion. 
Since the Insulin levels observed during the pig experiment were near 
the minimum detection limit of the assay, any possible decrease in 
insulin would be difficult to detect. 
In agreement: with our results, infusions of 50 ng*kg"^*min"^ EPI in 
humans have been shown to result in transient increases in plasma 
glucagon concentrations (25, 26). Other results with humans, however, 
have shown no significant changes in glucagon concentrations (20). In 
contrast though, the primed-dose constant infusion of 625 ng*kg'^*min~^ 
EPI in rabbits (16) produced a sustained increase in glucagon 
concentrations. 
Infusions of NOR have also produced conflicting glucagon responses. 
In agreement with our results, the infusion of 0.04 p,g*kg"^min"^ NOR in 
humans (28) produced a significant increase in glucagon levels within 30 
min. The infusion of 0.08 /ig*kg ^*min"^ for 170 min in humans, however, had 
no effect on glucagon concentrations (14). 
Cortisol is generally considered to be a catabolic hormone (18). 
Thus, an Increase in Cortisol levels may be expected to increase protein 
degradation. The continuous Infusion of NOR into the pigs approximately 
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doubled Cortisol concentrations. The finding that NOR infusion 
decreased the rate of proteolysis thou^, despite elevated Cortisol 
concentrations, may indicate an overriding influence of NOR on protein 
metabolism. 
The increase in Cortisol concentrations during the NOR infusion was 
similar to that which occurred after a bolus infusion of 1000 ptg/kg NOR 
in dogs (31). Bolus injections of 10 or 100 ptg/kg NOR in the dogs, 
however, failed to alter Cortisol concentrations. 
A 20 min infusion of 40 to 1000 ng*kg'^*min"^ EPI in rats (2) has 
been reported to produce a significant dose-related Increase in plasma 
corticosterone levels. The infusion of 500 ng*kg*^*min"^ EPI for one 
hour in dogs (31), however, produced no changes in Cortisol 
concentrations. Since the infusion of 100 ng*kg ^*min ^  EPI into the 
pigs in the present experiment also failed to influence Cortisol 
concentrations, these results may indicate species-related effects. 
Glucocorticoids are thou^t to be slow-acting, long-term regulators 
of blood glucose, maintaining for several hours the increase in glucose 
concentrations caused by EPI or glucagon (21). This may be accomplished 
by inhibiting insulin secretion and stimulating glucagon secretion (21) . 
It is possible that the stress level achieved during the NOR infusion in 
the pigs, may have been sufficient to stimulate a Cortisol effect on 
insulin and glucagon and aid in the maintenance of high glucose levels. 
Assuming the decrease in oxidation of the ketogenic amino acid 
leucine is reflected in the pattern of metabolism of the gluconeogenic 
amino acids, then the results from the NOR infusion suggest that 
liberation of energy-producing substrates from glycogen and adipose 
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tissue was adequate to meet the needs imposed by the artificial stress 
situation. The decrease in endogenous proteolysis, despite the fact 
that the animals were fasting, also emphasizes the reduced need for 
available amino acids. 
During the EPI infusion, the increases in the metabolites and 
hormones measured were not as dramatic as those which occurred during 
the NOR treatment. As a result, the rate of oxidation of free amino 
acids may have been maintained at the pre-EPI infusion level to 
supplement the provision of energy. Amino acids stored as protein were 
not affected thou^, as the rate of protein degradation was not 
increased. 
In conclusion, similar decreases in the rates of protein 
degradation and synthesis during the infusion of EPI, indicate an 
overall decrease in whole-body protein turnover, but no change in net 
protein synthesis. This should result in a conservation of energy, 
since protein turnover is an energy requiring process (24) . Decreases 
in the rates of proteolysis and protein synthesis during the infusion of 
NOR should likewise result in a conservation of energy. Furthermore, 
the decrease in the rate of oxidation with NOR will result in a 
conservation of nitrogen. Therefore, the results of this study suggest 
that during periods of stress, the conservation of energy resulting from 
changes in protein metabolism, will augment the desired increase in 
readily available energy. 
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ABSTRACT 
14 3 Using a constant infusion of [1- C]leucine and [4,5- H] 
0!-ketoisocaproate (KIC), the rates of whole-body leucine and KIC 
metabolism were estimated in young female lambs during acute infusions 
of the ^2 - adrenergic agonist cimaterol (CIM, 34 ^ g*kg"^*min~^), and 
during acute infusions of stress levels of epinephrine (EPI, 
0.1 fig*kg ^*min and norepinephrine (NOR, 2.0 ptg*kg~^*min"^). No 
significant changes in leucine metabolism resulted from saline or NOR 
infusions. EPI infusion decreased the rates of leucine entry 
(proteolysis and absorption) and protein synthesis by 10 and 13%, 
respectively (P<0.01), while CIM infusion decreased these rates by 34 
and 38%, respectively (P<0.1). Leucine and KIC interconversion was 
increased during the EPI infusion and reamination was decreased during 
the CIM infusion. NOR infusion significantly increased the plasma 
concentrations of free fatty acids (FFA), glucose, insulin and Cortisol. 
FFA, glucose and insulin were increased and glucagon was decreased as a 
result of the EPI infusion. The infusion of CIM resulted in increases 
in glucose and insulin and a decrease in glucagon concentration. These 
data indicate that, in addition to providing readily available energy 
through the liberation of glucose and FFA, the adrenergic compounds, EPI 
and CIM, reduce the rate of amino acid turnover but do not affect amino 
acid catabolism. 
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INTRODUCTION 
Daily injections of epinephrine (EPI) have been shown to influence 
nitrogen retention and body fat stores in pigs (9). This effect may be 
the result of stimulation of the ^-adrenergic receptors, since chronic 
administrations of specific jS-agonists to sheep (2, 6), pigs (19), 
cattle (27), poultry (11) and rats (12) have recently been shown to 
significantly alter body composition, producing an increase in muscle 
mass and a decrease in fat content. 
Catecholamines can be classified according to their stimulatory 
effects ona^-, /52-adrenergic receptors. As reviewed by 
Exton (13), epinephrine (EPI) stimulates all four receptor types, while 
norepinephrine (NOR) elicits responses only through , a^- and /3^-
adrenergic receptors. Skeletal muscle is generally considered to 
respond to stimulation with increased glycogenolysis and 
subsequent lactate release (13, 34). Several studies have indicated, 
however, that muscle protein turnover may also be specifically 
influenced by adrenergic stimulation. Perfusion of rat muscle with EPI 
or NOR decreases the rate of release of amino acids (15) and the rate of 
amino acid incorporation into prptein (40). Perfusion of rat 
gastrocnemius muscle (22) with isoproterenol O-agonist) decreases the 
rate of protein degradation, but has no effect on protein synthesis. In 
vivo studies also indicate that EPI infusion decreases the rate of 
endogenous proteolysis (24), but has no effect on oxidation (22). 
Experiments involving rats treated for 7 d with injections of either 
cleributerol or fenoterol (specific ^g-^gonists), have shown that this 
type of agonist increases the rate of protein synthesis in skeletal 
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muscle (12). No measurements were made, however, on other aspects of 
protein turnover which may influence total body protein content. Thus, 
the objective of the present experiment was to study the acute effects 
of infusions of EPI, NOR and cimaterol (CIM; a specific ^ g-agonist) on 
whole-body leucine metabolism (leucine entry from proteolysis and 
absorption, protein synthesis, leucine and a-ketoisocaproate (KIC) 
interconversion, and leucine oxidation), in sheep. Since the effects of 
these compounds on protein turnover may be indirectly influenced by 
concomitant changes in hormones and metabolites, plasma concentrations 
of insulin, glucagon, Cortisol, free fatty acids (FFA) and glucose were 
also measured. 
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MATERIALS AND METHODS 
14 L-[l- C] leucine (57 mCi/nmol) was purchased from Amersham and 
3 
L- [4,5- H]leucine (58 Ci/mmol) was purchased from ICN Biochemicals. 
3 3 [ H]KIC was enzymatically prepared from [4,5- H]leucine (29). The 
14 
NaH COg used was obtained from Calatomic. EPI and NOR (arterenol 
hydochloride) were obtained from Sigma Chemical. CIM was received as a 
gift from American Cyanamid. The drugs were dissolved in a 0.9% sodium 
chloride solution containing 0.2% serum albumin. NaH^PO^ H^O was added 
to the cm at 1.5 times its wei^t to aid in dissolving the drug in the 
saline (R.H. Dalrymple, American Cyanamid, Princeton, NJ, personal 
communication). 
On the day before the first isotope infusion, four young female 
sheep (40 kg) were fitted with an infusion catheter in the right 
ventricle via the right jugular vein, and a sampling catheter in the 
right atrium via the left Jugular vein. Each sheep was studied once 
with each of the four treatments (EPI, NOR, Cm and saline). One day of 
normal feeding separated each experiment day. Feed was removed 
approximately 12 h before the start of each experiment and water was 
available at all times. 
Two h before the start of the hormone infusions, a priming dose of 
14 5 pcCi NaH COg (1) was given, and a primed-dose constant infusion of 
[^H]KIC and [^^C]leucine (1.2 and 0.5 /nCi/min, respectively) was started 
to allow for isotope equlilibration. The priming dose was ten times the 
constant infusion dose for one minute. 
Before the start of the hormone infusions, blood samples were taken 
during the basal steady state period at -30, -20, -10 and 0 min. At 
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zero time, a 3 h constant infusion of epinephrine (0.1 pg*kg"^*min"^), 
norepinephrine (2.0 ng*kg ^*min ^), cimaterol (34 ng*kg"^*min~^) or the 
saline - albumin vehicle was started. Blood was then sampled at 60, 90, 
120, 150 and 180 min. The blood was collected into tubes containing 
EDIA and cooled immediately on ice. One ml of whole blood was added to 
tubes containing 3 ml 1.5 N perchloric acid and frozen at -80 C for 
later analysis. The remaining blood was centrifuged and the plasma was 
collected and stored at -80 C until analyzed for hormones and 
metabolites. Trasylol (500 U/ml of plasma) was added to the samples 
which were to be analyzed for glucagon. 
Whole-blood leucine and KIC concentrations were determined by hi^-
performance liquid chromatography (25). The HPLC effluent corresponding 
to the leucine or KIC peaks was collected and the and 
radioactivity determined by dual isotope liquid scintillation counting. 
Plasma glucose concentrations were determined using the glucose 
oxidase method (Worthington Diagnostics, Freehold, NJ). Free fatty 
acids were analyzed enzymatically (31) . Radioimmunoassays were used to 
125 
measure insulin (38), glucagon (16) and Cortisol (Gammacoat [ I] 
Cortisol Radioimmunoassay Kit, Travenol-Genetech Diagnostics). 
Rates of leucine entry (proteolysis and absorption), protein 
synthesis, KIC oxidation and interconversion of leucine and KIC were 
calculated as described by Helland et al. (17) for a reversible two-pool 
model. An independent estimate of the rate of KIC oxidation was also 
determined throu^ collection of breath ^^CO^. Expired air was 
collected in 30 liter latex balloons (Warren E. Collins, Inc.) for 2-3 
min periods at -30, 0, 90, 150 and 180 min. The air was slowly 
53 
aspirated through 250 ml of a 1 M ethanolamine solution. Triplicate 2 
ml samples of this solution were added to vials containing 15 ml of 
14 
scintillation cocktail and the C radioactivity determined in a liquid 
scintillation counter. CO^ flux was calculated as 
DPM expired*min ^)*(^^C-KIC specific radioactivity"^)*(kg"^) and 
corrected for 20% CO^ fixation in the body (1). 
It was subsequently determined that the plasma specific 
radioactivities of leucine and KIC were constant between 90 and 180 min 
after the start of the hormone infusions, and thus a new steady state 
had been established. The F test (32) was used to test for homogeneity of 
variance of the flux estimates. The variance between treatments was not 
homogeneous and therefore, the analysis of variance was not a valid test 
of differences between the treatments. The Student's t-test (32) was 
used to determine whether the change from the basal steady state period 
(mean of -30 to 0 min) to the final steady state period (mean of 90 to 
180 min), for each variable, was statistically different from zero. All 
data are expressed as means + SE. 
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RESULTS 
Whole-blood concentrations of leucine and KIC in the basal and 
final periods are presented in Table 1. Leucine concentrations 
decreased during the infusions of EPI (P<0.05) and CIM (P<0.1). No 
changes were observed in the whole-blood concentrations of KIC. 
The rates of Che sum of leucine entry from proteolysis and 
absorption, protein synthesis, leucine and KIC interconversion, KIC 
oxidation and breath CO^ flux for each treatment, are presented in Table 
1. No significant changes were found in any of the flux estimates when 
the sheep were infused with either saline or NOR for three hours. 
The infusion of EPI resulted in decreases of 10 and 13% in the 
rates of leucine entry and protein synthesis, respectively (P<0.01). In 
addition, deamination was increased by 18% (P<0.1) and reamination was 
increased by 28% (P<0.01). There were no significant effects of EPI 
infusion on KIC oxidation measured with either the two-pool model or 
breath COg. 
CIM infusion decreased the estimate of leucine entry by 34% 
(P<0.1) and the estimate of protein synthesis by 38% (P<0.1). The rate 
of reamination of KIC to leucine was also decreased by the CIM infusion 
(P<0.1). No effects of this compound were observed on leucine 
deamination or either measurement of KIC oxidation. 
Plasma FFÂ concentrations rapidly increased during the infusion of 
NOR, from 380 + 55 nmol/ml to a plateau concentration of 1658 + 91 
nmol/ml (Fig. 1). The infusions of EPI and CIM also increased the 
concentrations of FFÂ, althougjh the change from the basal to the final 
period was only significant with the EPI treatment (342 + 10 to 521 + 45 
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Table 1. Leucine and KIC concentrations and metabolism in sheep before, 
and during, infusion of saline, epinephrine, norepinephrine or 
cimaterol 
Saline Epinephrine Norepinephrine Cimaterol 
(N-4) (N-4) (N-4) (N-4) 
Concentrations^ 
Leucine 179 + 18 204 + 15 140 + 8 163 + 18 
F° 177 + 20 157 + 10* 1 4 4 + 5  89 + 5+ 
KIC B 13.9 + 1.0 15.0 + 1.6 14.3 + 0.6 12.7 + 0.8 
F 13.9 + 0.9 12.5 + 0.5 10.0 + 1.1 9.9 + 0.5 
Fluxes^ 
Leucine B 3.99 + 0.47 4.40 + 0.49 4.45 + 0.60 4.92 + 1.38 
entry F 3.50 + 0.03 3.96 + 0.44** 5.53 + 1.53 3.24 + 0.57+ 
Synthesis B 3.47 + 0.43 3.86 + 0.41 3.96 + 0.61 4.31 + 1.21 
F 3.01 + 0.07 3.35 + 0.39** 5.09 + 1.55 2.69 + 0.48+ 
Leu > KIC B 0.66 + 0.08 0.72 + 0.13 0.67 + 0.08 0.86 + 0.30 
F 0.60 + 0.06 0.85 + 0.15* 0.85 + 0.15 0.66 + 0.13 
KIC > Leu B 0.14 + 0.04 0.18 + 0.06 0.17 + 0.03 0.25 + 0.14 
F 0.12 + 0.01 0.23 + 0.08** 0.41 + 0.14 0.11 + 0.03+ 
Oxidation B 0.52 + 0.04 0.54 + 0.08 0.50 + 0.06 0.61 + 0.17 
F 0.49 + 0.06 0.61 ± 0.09 0.44 + 0.07 0.54 + 0.10 
CO. Flux B 0.65 + 0.15 0.73 + 0.18 0.54 + 0.06 0.56 + 0.15 6 F 0.45 + 0.09 0.^ + 0.08 0.81 + 0.19 0.39 + 0.09 
^nits: pM + SE, 
Basal time period (-30 to 0 min). 
^inal time period (90 to 180 min). -
units: ^ mol leucine or KIC*kg *min + SE. 
+ Change from basal to final period significantly different from 
zero (P<0.1). 
* Change from basal to final period significantly different from 
zero (P<0.05). 
** Change from basal to final period significantly different from 
zero (P<0.01). 
Figure 1. Plasma free fatty acid concentrations in sheep before, and 
during, infusion of saline, epinephrine, norepinephrine or 
cimaterol. Significance between basal and final periods is 
indicated by ** P<0.01 and * P<0.05, within a treatment. 
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nmol/ml, P<0.05). 
Glucose concentrations (Fig. 2) were significantly increased from 
the basal to the final period by the infusions of EPI, NOR and CIM (89 + 
6 to 141 +7, 97 + 4 to 264 + 15, 84 + 4 to 125 + 8 mg/dl, 
respectively). The most rapid increase in glucose concentrations 
occurred during the NOR Infusion, in which a plateau was reached by 
approximately 60 min. The other treatments caused more gradual changes 
in glucose levels. During the saline infusion, glucose decreased from 
105 + 10 to 93 + 7 mg/dl (P<0.01). 
During the infusion of saline into the sheep, a significant 
decrease in the plasma insulin concentration, from 0.71 ± 0.11 in the 
basal period to 0.54 + 0.08 ng/ml in the final period, was observed 
(Fig. 3). In contrast, infusions of EPI, NOR and CIM all significantly 
increased plasma insulin concentrations (0.90 + 0.11 to 1.57 + 0.35, 
P<0.1, 1.10 + 0.07 to 2.06 + 0.20, P<0.01, 0.50 + 0.06 to 2.73 + 0.85 
ng/ml, P<0.05, respectively). Although insulin concentrations were 
similar at 150 min after the start of the NOR and CIM infusions, the 
peak in insulin occurred one hour earlier during the CIM infusion than 
during the NOR infusion. 
No significant changes in glucagon concentrations occurred during 
the infusions of either saline or NOR (Fig. 4). The infusions of EPI 
and CIM, however, resulted in decreases in the plasma concentrations of 
glucagon from the basal to the final period (442 + 54 to 363 + 67, 
P<0.05, 393 + 108 to 265 + 41 pg/ml, P<0.1, respectively). 
The insulin to glucagon ratio (I/G) was affected by all treatments 
(Fig. 5). The saline infusion produced a decrease in I/G from 1.55 + 
Figure 2. Plasma glucose concentrations in sheep before, and during, 
infusion of saline, epinephrine, norepinephrine or cimaterol. 
Significance between basal and final periods is indicated by 
** P<0.01 and + P<0.1, within a treatment. 
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Figure 3. Plasma insulin concentrations in sheep before, and during, 
infusion of saline, epinephrine, norepinephrine or cimaterol. 
Significance between basal and final periods is indicated by 
** P<0,01, * P<0.05 and + P<0.1, within a treatment. 
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Figure 4. Plasma glucagon concentrations in sheep before, and during,. 
infusion of saline, epinephrine, norepinephrine or cimaterol. 
Significance between basal and final periods is indicated by 
** P<0.01 and + P<0.1, within a treatment. 
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Figure 5. Insulin to glucagon ratios in sheep plasma before (basal), 
and during (final), Infusions of saline, epinephrine, 
norepinephrine or cimaterol. Significance between basal and 
final periods is indicated by ** P<0.01, * P<0.05 and 
+ P<0.1, within a treatment. 
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0.31 in the basal period to 1.13 + 0.28 in the final period (P<0.05). 
The infusions of EPI and NOR tended to increase I/G (2.11 + 0.25 to 5.05 
+ 1.67, 2.99 + 0,55 to 5.79 + 1.23, P<0.1, respectively), while CIM 
infusion resulted in a dramatic increase in I/G from 1.48 + 0.27 to 
10.26 + 1.93 (P<0.01). 
Cortisol concentrations were significantly altered only during the 
infusion of NOR (Fig. 6), in which a rise from 2.69 + 0.46 in the basal 
period to 16.56 + 1.80 /Ltg/dl (P<0.01) in the final period, was observed. 
Figure 6. Plasma Cortisol concentrations in sheep before, and during,, 
infusion of saline, epinephrine, norepinephrine or ciraaterol. 
Significance between basal and final periods is indicated by 
** P<0.01, within a treatment. 
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DISCUSSION 
The infusion rates of EPI and NCR used in this experiment were 
designed to mimic levels which would be expected in stress situations. 
Blum et al. (7) noted that an infusion of approximately 72 ng*kg'^*min"^ 
EPI in fed cattle resulted in a plasma EPI concentration of about 1500 
pg/ml. An infusion of 50 ng*kg ^*min ^  EPI in humans (28) resulted in 
an increase in the plasma EPI concentration from 34 to 776 pg/ml and no 
change in plasma NOR concentration. Stresses such as exercise in man 
(14) and food deprivation in dogs (21) have been reported to result in 
EPI concentrations of 400 to 700 pg/ml. 
Infusions of 40 (30) and 80 ng*kg ^min ^ (20) NOR in humans have 
been reported to raise plasma NOR concentrations to 1500 to 1800 pg/ml. 
Because these NOR levels were not as hi^ as those which have been 
reported to occur during stresses (14, 21, 35) such as exercise (2200 
pg/ml) , food deprivation (2800 pg/ml) or myocardial infarction (4100 
-1 -1 pg/ml), an infusion rate of 2000 ng*kg *min was chosen. The levels 
of EPI and NOR infused are markedly different and thus, no direct 
comparisons between the effects of the two hormones can be made. 
The CIM infusion rate used was equal to the amount which, when 
administered parenterally to lambs by osmotic minipumps (10) , produced 
significant changes in body composition. 
The lack of a significant effect of NOR infusion on whole-body 
leucine metabolism in the sheep, is in contrast to the response observed 
in pigs (Section I), in which a 2 h NOR infusion caused decreases in 
proteolysis, protein synthesis, leucine and KIC interconversion and 
oxidation. Similar to pigs, rat muscle also responded to NOR perfusion 
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by decreasing the rate of release of glutamine and alanine into the 
medium (15) and the rate of amino acid incorporation into protein (40). 
These studies may indicate that the response of muscle in ruminants to 
noradrenergic stimulation is different than that in nonruminants. 
The concentrations of glucose, FFA and glucagon during the NOR 
infusion all peaked at 60 min, while insulin concentrations were just 
beginning to rise. This indicates that the effect of NOR infusion on 
insulin may have been of a suppressive nature initially (3), while 
subsequent changes may have been the result of alterations in 
metabolites or other hormones such as glucagon (4). 
The rise in the plasma concentrations of FFA, concomitant with an 
increase in glucagon, during the NOR infusion, is consistent with 
reports of lipolytic actions of NOR (33) and glucagon (4). This effect 
seemed to be obscured after 60 min, however, by the rise in the 
ahtilipolytic hormone insulin. 
NOR infusion increased the plasma Cortisol concentration 
approximately sixfold in the sheep. Because no significant change in 
protein degradation was observed during the NOR infusion, despite 
elevated levels of the catabolic.hormone Cortisol, it is possible that 
NOR and. Cortisol had offsetting effects on proteolysis. 
EPI infusion in the sheep produced significant decreases in both 
leucine entry (proteolysis and absorption) and protein synthesis. These 
results agree with those found in pigs during infusions of EPI (Section 
I). Other research has also indicated that EPI caused decreased release 
of amino acids from muscle in vitro (15) and decreased appearance of 
leucine carbon in the plasma of humans (24). 
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The Infusion of EPI produced no significant changes in the rate of 
KIC oxidation in the sheep. This is consistent with the results 
obtained with EPI infusion in pigs (Section I) and dogs (23). In vitro 
research (8) has indicated though, that perfusion of rat diaphragm 
muscle with EPI Increased the rate of amino acid catabolism when glucose 
and pyruvate were omitted from the medium. 
EPI infusion resulted in increased (P<0.01) reamination of KIC to 
leucine and a marginal increase (P<0.1) in leucine deamination. 
Interconversion between the branched-chain amino acids and their keto 
acids is catalyzed by a specific transaminase which occurs in a variety 
of tissues (18). Since the leucine model used in this study reflects 
the stim of changes in interconversion in the whole-body thou^, it is 
not possible to determine the magnitude of changes in any particular 
organ, or to predict which organs may have been influenced by the 
increased shuttling of leucine and KIC. 
The plasma concentrations of glucose, FFA and insulin all increased 
from the start of the EPI Infusion. FFA concentrations peaked at 60 
min, however, while the levels of glucose and insulin continued to rise 
until 150 min. Glucagon concentrations were stable until 60 min, but 
subsequently decreased until the end of the experiment. These data 
suggest that EPI directly influenced glucose and FFA metabolism and the 
release of insulin from the pancreas, because the Increases were 
observed during the early infusion period. The effects of EPI on 
glucose homeostasis may be the result of /3-adrenergic stimulation of 
muscle and liver glycogenolysis and liver gluconeogenesis (13). 
The infusion of the -agonist CIM in the sheep, produced marginal 
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decreases (P<0.1) in the rates of leucine entry and protein synthesis. 
Because no significant changes occurred in the rate of KIC oxidation, 
however, no effect would be expected in the net protein synthesis rate 
(synthesis - proteolysis). 
During the CIM infusion, the I/G ratio dramatically increased, 
indicating a more anabolic situation. Inconsistent with this was an 
increase in glucose concentrations from 60 to 120 min. It has been 
previously noted, however, that glucose and insulin concentrations in 
ruminants are not well related (37). 
In contrast to the increase in insulin which occurred during the 
acute infusion of the jg-agonist CIM, Beerman et al. (5) indicated in a 
preliminary report, that the chronic feeding of CIM to 17 kg lambs, for 
6 or 12 weeks, resulted in decreases in insulin concentrations of 50%. 
Insulin was also found to decrease following injections of fenoterol for 
19 d in rats (12) , althou^ no change in insulin was observed following 
16 d of clenbuterol injections. Tepperman (35) notes that chronic 
stimulation can cause down-regulation of ^ -receptors. The differences 
in insulin response to acute versus chronic stimulation suggest that the 
latter may cause down-regulation of receptors in the pancreas. 
FFA concentrations during the CIM infusion increased initially but 
were not changed significantly between the basal and final periods. 
Other research has indicated that both acute (7) and chronic (5) /3-
receptor stimulation result in increases in FFA levels in ruminants. 
There may be species-related differences in the response of 
glucocorticoids to adrenergic stimulation. In rats, EFI produced a 
dose-related increase in corticosterone and ACTH (36) , but in the 
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present experiment, no changes in Cortisol were observed during either 
the EPI or CIM infusions. The response to EPI in rats (36) could be 
blocked with propranolol ( ^-adrenergic antagonist) and mimicked with 
isoproterenol (/S-adrenergic agonist), indicating a )3-stimulated 
response. Because isoproterenol -exhibits both and actions (39) 
and no effect on Cortisol was seen following acute (Fig. 6) or chronic 
(5) administrations of CIM (/S^-agonist), these data suggest that the 
effect is mediated via receptors. This could also account for the 
NOR effect since, as it was previously noted, NOR has but little 
action (13). 
Previous research has indicated that the rate of protein synthesis 
in rat skeletal muscle is increased upon chronic treatment of the 
animals with agonists (12). Furthermore, numerous experiments have 
shown that chronic administration of ^ g-agPaists causes dramatic 
increases in the muscle content and decreases in the quantity of adipose 
tissue in several species (2, 6, 11, 12, 19, 27), including sheep. A 
major reason why the present acute study may not have duplicated effects 
seen in the chronic studies, is that the acute study only covers a short 
time period during one part of the absorptive stage. Dixxmal changes 
not reflected in this experiment may influence the responsiveness of the 
animals to these compounds. Other factors which may cause differences 
between the chronic and acute studies include alterations in the 
relative changes in levels of various hormones or metabolites, as 
affected by down-regulation, and changes in blood flow which could 
influence the partitioning of substrates to each tissue. 
In conclusion, these experiments indicate that in sheep, acute 
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elevations of EPI to levels seen in stress, may cause a decrease in the 
rate of whole-body protein turnover, but no change in catabolism. 
Similarly, Infusion of the jS-agonist CIM also results in a decrease in 
protein turnover. A reduced requirement for energy will be associated 
with these changes in protein metabolism (26) and thus, indirectly 
increase the supply of readily available energy for other metabolic 
processes. 
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GENERAL DISCUSSION 
Epinephrine (EPI) and norepinephrine (NOR) were infused at levels 
which were designed to mimic concentrations of these hormones in stress 
situations and thus, NOR was infused at a rate 20 times that of EPI. The 
level of cimaterol (CIH) used was- one which had been found to affect 
muscle and fat deposition when chronically infused into lambs. 
Therefore, any comparison of the effects of these compounds is only 
relevant for the specific dosages employed. 
A cross-species evaluation of the results from these experiments is 
dependent on the recognition of the inherent differences between 
ruminant and nonruminant animals. It was impractical to attempt these 
studies at the same stage of nutrient absorption because of the 
difficulty in fasting ruminants and because other work in our laboratory 
had shown that pigs refused feed during catecholamine infusions. 
Therefore, differences exist in the amount of time each species was 
without feed before measurements were begun. It is likely that the 
effects of these compounds on mobilization of body stores for energy are 
dependent, to some extent, on the absorption of substrates from the 
diet. Buse et al. (4) noted that in vitro stimulation of leucine 
oxidation by EPI only occurred in diaphragms from fasted animals, and 
when glucose and pyruvate were omitted from the media. 
Given these reservations about comparisons among experiments, an 
evaluation of the results of these trials indicates a great number of 
similarities. Figure 1 summarizes the changes in protein metabolism 
and the plasma concentrations of the hormones and metabolites studied, 
as a result of infusion of each adrenergic substance. Disregarding the 
Figure 1. Summary of changes In protein metabolism and the plasma 
concentrations of hormones and metabolites, during Infusions 
of adrenergic compounds In pigs and sheep. Significance at 
P<0.05 denoted by closed arrows. Significance at P<0.1 
denoted by open arrows. 
84 
EPINEPHRINE NOREPINEPHRINE CIIUTEROL 
PIGS SHEEP PI6S SHEEP 
LEUCINE ENTRY I i 
SYNTHESIS i i 
LEII -) KIC î 
KIC -) LEU î 
OXIDATION 
GLUCOSE f î 
FFA î 
CORTISOL 
GLUCAGON î 
INSULIN î 
I 
i 
î 
î 
î 
SHEEP 
& 
& 
& 
î 
î 
& 
î 
85 
magnitude of response, the changes which occurred were generally the 
same, both between species and-among compounds. -The only exceptions to 
this are the interconversions of leucine and KIC and the glucagon 
response. A decrease in interconversion of leucine and KIC during the 
NOR infusion in pigs and a decrease in reamination during the CIM 
infusion in sheep, contrasts with the increase in interconversion during 
the EPI infusion in sheep. In addition, contrary to the decrease in the 
glucagon concentration observed during the CIM infusion in sheep, 
positive glucagon responses were stimulated during the EPI infusion in 
sheep and the NOR infusion in pigs. 
Overall, the protein kinetic data indicate that catecholamines 
affect the degradation of protein in the whole animal. It does not 
seem, however, that this decrease results in more efficient nitrogen 
conservation, because oxidation was not consistently decreased. 
The decrease in whole-body protein turnover which occurred in all 
of the experiments, except the NOR study in sheep, should result in a 
conservation of energy. This will further supplement the energy 
availability from body stores and aid in the maintenance of the 
internal environment during periods of stress. 
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APPENDIX 
Table 1. Leucine metabolism in pigs during infusions of saline, 
epinephrine or norepinephrine 
Saline Epinephrine Norepinephrine 
(N-2) (N-6) (N-6) 
% 
Proteolysis -8.8 + 5.1 -10.7 + 1.9** 
CO a
 
1 + 2.6** 
Synthesis -10.5 + 1.4 -14.4 + 3.8* -26.3 + 2.4** 
Leu -> KIC 9.2 + 20.3 5.9 + 12.0 -31.1 + 6.7** 
KIC > Leu 15.4 + 21.5 6.6 + 16.3 -35.0 + 8.3** 
Oxidation -4.2 + 21.2 80.0 + 55.2 
o
 1 + 5.4* 
Percentage change between basal (-15 to 0 min) and final periods 
(75 to 120 min). 
* Change from basal to final period significantly different from 
zero (P<0.05). 
** Change from basal to final period significantly different from 
zero (P<0.01). 
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Table 2. Leucine metabolism In sheep during infusions of saline, 
epinephrine, norepinephrine or cimaterol 
Saline Epinephrine Norepinephrine Cimaterol 
(N-4) (N-4) (N-4) (N-4) 
% 
Leucine entry -8, .7 + 10. 5 -9 .9 + 1 .0** 20 .5 + 18. 2 -26.8 + 10. ,4+ 
Synthesis -9. 7 + 9. 7 -13. 5 + 2 .1** 24, .0 + 19. 9 -30.5 + 10. ,3+ 
Leu -> KIC -1. 6 + 19. 6 19, .0 + 7 .4+ 31, .4 + 25. 9 -8.7 + 14. 7 
KIC -> Leu 7. 8 + 30. 8 31, .0 + 5 .1** 160. 4 + 7 7 .  7 -33.4 + 13. 5+ 
Oxidation -2. 7 + 17. 5 15. 0 + 8, .6 -12. 9 + 9. 3 -0.6 + 12. 8 
Percentage change between basal (-30 to 0 min) and final periods 
(90 to 180 min). 
+ Change from basal to final period significantly different from 
zero (P<0.1). 
* Change from basal to final period significantly different from 
zero (P<0.05). 
** Change from basal to final period significantly different from 
zero (P<0.01). 
Figure 1. Breath flux versus two-pool model KIC oxidation, at -30 
and 0 min (basal) and 150 and 180 min (final), during all 
2 
treatments, in sheep. Y - 0.41 + 0.26*X, R - 0.03. 
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